![]() Lexaria’s DehydraTECH formulation delivers over a tenfold amount of CBD to the bloodstream than conventional industry formulations. Overall, roughly a ten-fold increase in product volumes manufactured by Nuka utilizing DehydraTECH is expected over the next 18 months.Īs part of its mission to bring cannabis back to its pre-prohibition status as widely used medicine, Nuka says it will also begin using DehydraTECH to create consumer products containing CBD. Over the next two years, 1906 is expanding its product offerings to other legal markets including: Illinois, Ohio, Massachusetts, and Michigan. “We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”Ĭurrently, 1906 offers six distinct formulations that combine low-dose cannabis with targeted plant medicines. “As the fastest growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology,” said Nuka Enterprises co-founder and CEO Peter Barsoom in a statement. READ: Lexaria’s DehydraTECH formulation delivers over tenfold CBD to bloodstream than conventional industry formulations Last year, Nuka acquired contractual options to expand its use of Lexaria’s DehydraTECH technology which delivers cannabinoids (CBD) to the bloodstream more quickly and effectively than conventional industry CBD edible formulations.Įxercising some of those options, Nuka plans to expand operations for cannabis chocolates and edibles in six additional states and cannabis beverages in three states in 20. ![]() Lexaria Bioscience Corp ( CSE:LXX) (OTCMKTS:LXRP) announced Tuesday that the “most reliable, fast-acting edibles” on the market will now be available across the country through a major expansion in operations by Nuka Enterprises LLC, maker of 1906 cannabis edibles for adults.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |